论药品强制许可对国际直接投资的影响

随着专利法的修订,药品强制许可的法律依据依然完善。然而,药品研发的高额成本,必然导致制药企业本能地抵制药品强制许可。同时,制药企业将避免前往实施强制许可的国家进行直接投资。因此,药品强制许可对制药业投资的影响,亟待评估。有必要透视全球药品强制许可的立法和实践,通过分析TRIPs协定相关内容,考察药品强制许可对国际直接投资的影响。

The ImpactofCompulsoryLicensingtoPatentedMedicines toFDI

Compulsory licensing to patented medicines is favaborable for developing countries to provide their patients with patented medicines at low price.For the patentees,they are obviously aginst compulsory licensing and may avoid not to invest in the countries which adopt compulsory licensing.The article elaborates legislations and practices in some countries based on TRIPs and analyzes the impact of compulsory licensing to patented medicines to FDI.